Trade Cytek Biosciences Inc - CTKB CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.07 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.02354% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001318% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 20.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 3.67 |
| Open | 3.57 |
| 1-Year Change | -3.25% |
| Day's Range | 3.57 - 3.72 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 30, 2025 | 3.67 | 0.14 | 3.97% | 3.53 | 3.71 | 3.53 |
| Apr 29, 2025 | 3.71 | -0.06 | -1.59% | 3.77 | 3.83 | 3.67 |
| Apr 28, 2025 | 3.82 | 0.09 | 2.41% | 3.73 | 3.83 | 3.69 |
| Apr 25, 2025 | 3.73 | 0.02 | 0.54% | 3.71 | 3.77 | 3.67 |
| Apr 24, 2025 | 3.77 | 0.03 | 0.80% | 3.74 | 3.78 | 3.69 |
| Apr 23, 2025 | 3.73 | -0.11 | -2.86% | 3.84 | 4.01 | 3.73 |
| Apr 22, 2025 | 3.75 | 0.07 | 1.90% | 3.68 | 3.80 | 3.68 |
| Apr 21, 2025 | 3.67 | 0.26 | 7.62% | 3.41 | 3.68 | 3.36 |
| Apr 17, 2025 | 3.61 | 0.10 | 2.85% | 3.51 | 3.64 | 3.50 |
| Apr 16, 2025 | 3.64 | 0.14 | 4.00% | 3.50 | 3.70 | 3.50 |
| Apr 15, 2025 | 3.68 | -0.01 | -0.27% | 3.69 | 3.76 | 3.63 |
| Apr 14, 2025 | 3.73 | 0.05 | 1.36% | 3.68 | 3.76 | 3.64 |
| Apr 11, 2025 | 3.67 | 0.22 | 6.38% | 3.45 | 3.68 | 3.45 |
| Apr 10, 2025 | 3.49 | -0.04 | -1.13% | 3.53 | 3.61 | 3.43 |
| Apr 9, 2025 | 3.70 | 0.45 | 13.85% | 3.25 | 3.78 | 3.25 |
| Apr 8, 2025 | 3.33 | -0.38 | -10.24% | 3.71 | 3.71 | 3.26 |
| Apr 7, 2025 | 3.64 | 0.05 | 1.39% | 3.59 | 3.92 | 3.48 |
| Apr 4, 2025 | 3.67 | 0.09 | 2.51% | 3.58 | 3.71 | 3.48 |
| Apr 3, 2025 | 3.68 | -0.16 | -4.17% | 3.84 | 3.87 | 3.68 |
| Apr 2, 2025 | 3.96 | 0.13 | 3.39% | 3.83 | 4.06 | 3.83 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 20
- 100
- 500
- 1000
- 10000
Cytek Biosciences Inc
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. The company offers aurora and northern lights systems delivers cell analysis; aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; enhanced small particle detection; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. It also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments. In addition, the company offers automated micro-sampling system and automated sample loader system, an automated loaders designed to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. It serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. The company distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in Europe, Latin America, and the Middle East countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.News
GME shares price forecast: Third-party price target
Read our GameStop (GME) share price forecast for 2025 and beyond, with insights from third-party analysts and market experts
11:40, 28 April 2025
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com